Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Similars in SciELO
Share
Acta médica Grupo Ángeles
Print version ISSN 1870-7203
Abstract
NAVARRETE HORTA, Teresa; GUERRERO CARRENO, Francisco Javier; VALDES AGUERREBERE, Paulina and VAZQUEZ ESTRADA, Leopoldo Alejandro. Estetrol: a new paradigm in gynecological therapy?. Acta méd. Grupo Ángeles [online]. 2022, vol.20, n.1, pp.50-57. Epub Oct 10, 2022. ISSN 1870-7203. https://doi.org/10.35366/103556.
Estetrol (E4) is a natural estrogen produced by the human fetus and passes into the maternal blood at relatively high levels during pregnancy. Over the past two decades, its pharmacodynamic and pharmacokinetic profiles, tolerability, and safety margin have been shown to be highly favorable. In this sense, E4 potentially represents a great advance in gynecological therapy such as contraception and the management of menopause. E4 also shows applicability in other therapeutic fields such as hormone-dependent cancers (breast and prostate), osteoporosis, neuroprotection, muscle pain, and wound healing. We present hereinafter the current evidence on this “new” hormonal therapy option whose inclusion in gynecological clinical practice seems imminent.
Keywords : Estetrol; E4; contraception; menopause; hormonal therapy.